ArticleJournal of Alzheimer's disease reports
Cognitive impairment in cerebellar phenotype of multiple system atrophy and its association with hot-cross bun sign.
Article in Journal of Alzheimer's disease reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neural Correlates of Apathy in Multiple System Atrophy: A Clinical and Perfusion Imaging Study.European journal of neurology · 2026Article
- The Emotional Landscape of Multiple System Atrophy: A Preliminary Personality-Based Perspective.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cognitive impairment has been reported in patients with cerebellar phenotype of multiple system atrophy (MSA-C), yet this area remains largely unexplored. Objective: We evaluated the cognitive profile of MSA-C patients and assessed its association with neuroimaging features, specifically the hot-cross bun (HCB) sign. Methods: This retrospective study encompassed 210 patients diagnosed with MSA-C between 2019 and 2023. Each patient underwent a thorough clinical evaluation, a comprehensive neuropsychological assessment and a magnetic resonance imaging (MRI) scan. Results: MSA-C patients demonstrated a high burden of comorbidities, including a high frequency of motor symptoms, autonomic disorders, and various non-motor symptoms such as cognitive deficits, mood disorders and sleep disturbances. Notably, 24.8% of MSA-C patients exhibited cognitive impairment, primarily affecting language, memory and processing speed. The presence of the HCB sign was independently associated with cognitive impairment, whereas other clinical features, such as orthostatic hypotension, were not. MSA-C patients with the HCB sign demonstrated significantly poorer performance in language, visuospatial function, and processing speed. Conclusions: MSA-C patients suffer a substantial burden of cognitive impairment, primarily affecting language, memory and processing speed. Notably, the HCB sign is a significant indicator for cognitive dysfunction in patients with MSA-C.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.